Pink SheetAn advisory committee to Japan’s Ministry of Health, Labour and Welfare (MHLW) has recommended the approval of eight new drugs, including a global-first indication for Eisai Co., Ltd. ’s ultra-high d
Generics Bulletin“A solid start of the year” is how Gedeon Richter described its performance during the first quarter of 2024. The Hungarian firm reported HUF200bn ($564m) in pharma revenues, which was a 12.6% year-
Scrip“We’ve seen some tremendous acceleration in science over the past few years and that science is the driving force behind new medicines. The fundamental need for these new medicines is the underpinning
Generics BulletinExecutive changes in the off-patent medicines industry throughout 2023 reflected a growing interest in the innovator side of the life sciences sector among leading generics and biosimilars companies.